clinical trial · NCT05953402
A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
Bristol-Myers Squibb·—·not yet recruiting·n = 1,182
Ulcerative Colitis
brief summary
The purpose of this study is to evaluate association between ozanimod exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.
started
Dec 3, 2025
primary completion
Jun 29, 2033
completion
Jun 30, 2033
last updated
Dec 3, 2025
official title
ZEPOSIA® (Ozanimod) Ulcerative Colitis Pregnancy Registry: a Prospective, Observational Study on the Safety of Ozanimod Exposure in Pregnant Women With Ulcerative Colitis and Their Offspring
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol